Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by StockDudeLolon Nov 29, 2016 3:26pm

51 Views

Post# 25529415

RE:RE:RE:RE:ye hah back to business

Orbital14 wrote: LOL sure is an exciteable bunch. 4 days of slaughter and a 1 penny move up and its party time. With the news today this thing should have been back up to .23 at least. Hell, if the CEO didn't sell out I would have maybe considered getting back in as the revenues make more sense with the new space. There is always the fact they don't actually have an office though, that's odd.

There is a lot to like, and a lot to be worried/puzzled over.

Bullboard Posts

Increasing summer travel could see these airline stocks soar